Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Waran Seri I Pyridam Farma Tbk. (PYFA-W) vs Sarana Menara Nusantara Tbk. (TOWR) Price & Performance

Waran Seri I Pyridam Farma Tbk.Trade
Sarana Menara Nusantara Tbk.Trade

Price performance (Past 24H)

Key statistics

Waran Seri I Pyridam Farma Tbk. vs Sarana Menara Nusantara Tbk. — how do they compare? Waran Seri I Pyridam Farma Tbk. trades at Rp62 (market cap 11.05B, 76.4K 24h volume), while Sarana Menara Nusantara Tbk. trades at Rp388 (market cap 23.17T, 43.43M 24h volume). The key difference: Sarana Menara Nusantara Tbk. is far larger — about 2096.8× Waran Seri I Pyridam Farma Tbk.'s market cap, and Sarana Menara Nusantara Tbk. is more actively traded (43.43M versus 76.4K). Which is the better fit depends on your goals.

PYFA-WTOWR
Market Cap
11.05B23.17T
Volume
76.4K43.43M
Lot
764434.3K
Turnover
4.59M16.85B
Average Price
60.09387.95
Value
4.59M16.85B
Indicative Equilibrium Price
388
Indicative Equilibrium Volume
3.03K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

TOWR
View details

About Waran Seri I Pyridam Farma Tbk.

PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.

Read more on PYFA-W

About Sarana Menara Nusantara Tbk.

PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering

Read more on TOWR